These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37083543)

  • 21. Knowledge gaps between nanotoxicological research and nanomaterial safety.
    Hu X; Li D; Gao Y; Mu L; Zhou Q
    Environ Int; 2016 Sep; 94():8-23. PubMed ID: 27203780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicology of nanomaterials used in nanomedicine.
    Zhao J; Castranova V
    J Toxicol Environ Health B Crit Rev; 2011; 14(8):593-632. PubMed ID: 22008094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
    Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
    J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma biology and treatment: a review of novel regulated cell death-based approaches.
    Hsieh MY; Hsu SK; Liu TY; Wu CY; Chiu CC
    Cancer Cell Int; 2024 Feb; 24(1):63. PubMed ID: 38336727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Die hard: cell death mechanisms and their implications in nanotoxicology.
    Lomphithak T; Fadeel B
    Toxicol Sci; 2023 Feb; 192(2):141-54. PubMed ID: 36752525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNAs and regulated cell death in tumor cells.
    Wu Y; Wen X; Xia Y; Yu X; Lou Y
    Front Oncol; 2023; 13():1170336. PubMed ID: 37313458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials.
    Andón FT; Fadeel B
    Acc Chem Res; 2013 Mar; 46(3):733-42. PubMed ID: 22720979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
    Ryter SW
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine and epigenome. Possible health risks.
    Smolkova B; Dusinska M; Gabelova A
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):780-796. PubMed ID: 28705729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
    Zhang C; Liu N
    Front Immunol; 2022; 13():920059. PubMed ID: 35958626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular toxicity of nanomaterials.
    Chang XL; Yang ST; Xing G
    J Biomed Nanotechnol; 2014 Oct; 10(10):2828-51. PubMed ID: 25992420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook.
    Sepand MR; Ranjbar S; Kempson IM; Akbariani M; Muganda WCA; Müller M; Ghahremani MH; Raoufi M
    Nanomedicine; 2020 Oct; 29():102243. PubMed ID: 32623018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.
    Wang X; Hua P; He C; Chen M
    Acta Pharm Sin B; 2022 Sep; 12(9):3567-3593. PubMed ID: 36176912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional Nanomaterials for Ferroptotic Cancer Therapy.
    Shi Z; Zheng J; Tang W; Bai Y; Zhang L; Xuan Z; Sun H; Shao C
    Front Chem; 2022; 10():868630. PubMed ID: 35402376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomaterials in biology and medicine: a new perspective on its toxicity and applications.
    Saravanan J; Nair A; Krishna SS; Viswanad V
    Drug Chem Toxicol; 2024 Sep; 47(5):767-784. PubMed ID: 38682270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
    Gao W; Wang X; Zhou Y; Wang X; Yu Y
    Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular signal modulation by nanomaterials.
    Hussain S; Garantziotis S; Rodrigues-Lima F; Dupret JM; Baeza-Squiban A; Boland S
    Adv Exp Med Biol; 2014; 811():111-34. PubMed ID: 24683030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotoxicity: the growing need for in vivo study.
    Fischer HC; Chan WC
    Curr Opin Biotechnol; 2007 Dec; 18(6):565-71. PubMed ID: 18160274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison.
    de Miguel D; Ramirez-Labrada A; Uranga I; Hidalgo S; Santiago L; Galvez EM; Arias M; Pardo J
    FEBS J; 2022 Aug; 289(15):4398-4415. PubMed ID: 34174027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.